Array 20

Blood-Brain Barrier Permeability™

Array 20

Blood-Brain Barrier Permeability™

Assists in the assessment of increased risk of neurodegenerative disorders, including but not limited to Multiple Sclerosis, Lou Gehrig's Disease, Senile Dementia, Alzheimer's Disease, Parkinson's Disease, Epilepsy and Stroke. Helps in the early investigation of contact sports-related Traumatic Brain Injury (TBI), and evaluates the breach of Blood-Brain Barrier caused by stress, trauma or environmental triggers, even in the absence of apparent concussion or brain injury.

Clinical Use

Early investigation in management of contact sports-related Traumatic Brain Injury (TBI)
Evaluation of breach of the Blood-Brain Barrier by stress, trauma or environmental triggers, even in the absence of apparent concussion or brain injury
Assist in the assessment of increased risk of neurodegenerative disorders including, but not limited to, Multiple Sclerosis, Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease), Senile Dementia, Alzheimer's Disease, Parkinson's Disease, Epilepsy and Stroke

Recommended for Patients Who

Play contact sports during which repeated head trauma occurs
Engage in activity that involves force or shock to the body and/or head
Have intestinal permeability with abnormal elevation in LPS and/or Occludin/Zonulin antibodies
Exhibit changes in cognitive function

Antigens Tested

Blood-Brain Barrier Protein IgG + IgA combined
Blood-Brain Barrier Protein IgM

CPT® CODE : 83516 (x2)

Blood-Brain Barrier Permeability

Contact Us

If you have any question you would like to know more about the
Array 2 - Intestinal Antigenic Permeability Screen™.

To Get Started

Cyrex Laboratories works with licensed healthcare professionals throughout the United States.
Create a healthcare professional account now!

If you're already a Cyrex Labs account holder, click here to log into your account to download additional materials.